1.Wang X, Chen X, Zhuang M, Fu C, Garcia R, Müller R, Zhang Y,Yan J*, Wu D*, Huo L*. Discovery and characterization of a myxobacterial lanthipeptide with unique biosynthetic features and potent anti-inflammatory activity. J Am Chem Soc. 2023;145(30):16924-16937. *Co-corresponding author.
2.Kang J#,Yan J#, Zhang X, Turner J, Abraham C. Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation. Gastroenterology. 2020;159(3):1051-1067. # Co-first authorship.
3.Yan J, Pandey S, Turner J, Barnes B, Abraham C. T Cell-Intrinsic IRF5 Regulates T Cell Signaling, Migration, and Differentiation and Promotes Intestinal Inflammation. Cell Rep. 2020;31(13):107820.
4.Yan J, Hedl M, Abraham C. Myeloid Cell-Intrinsic IRF5 Promotes T Cell Responses through Multiple Distinct Checkpoints In Vivo, and IRF5 Immune-Mediated Disease Risk Variants Modulate These Myeloid Cell Functions. J Immunol. 2020;205(4):1024-1038.
5.Pandey S#,Yan J#, Abraham C. Reducing IRF5 expression attenuates colitis in mice but impairs the clearance of intestinal pathogens. Mucosal Immunol. 2019;12(4):1065. #Contributed equally;
6.Yan J, Hedl M, Abraham C. An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes. J Clin Invest. 2017;127(6):2192-2205.
